These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 579434)

  • 1. Experience of antioxidant treatment in neuronal ceroid-lipofuscinosis of Spielmeyer-Sjögren type.
    Santavuori P; Moren R
    Neuropadiatrie; 1977 Nov; 8(4):333-44. PubMed ID: 579434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant therapy in neuronal ceroid-lipofuscinosis.
    Santavuori P; Westermarck T
    Med Biol; 1984; 62(2):152-3. PubMed ID: 6471935
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current viewpoints of Sjögren's syndrome].
    De Landsheere D; Van Cauwenberge P
    Acta Otorhinolaryngol Belg; 1984; 38(2):177-85. PubMed ID: 6435389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Gougerot-Sjögren syndrome].
    Hatron PY; Delesalle JC; Lacroix G; Gosset D; Vinckier L; Devulder B
    Rev Prat; 1986 Apr; 36(23):1287-98. PubMed ID: 3715349
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Sjogren's syndrome by traditional Chinese medicine (author's transl)].
    Zhang WZ
    Zhonghua Kou Qiang Ke Za Zhi; 1982; 17(1):51-3. PubMed ID: 6955158
    [No Abstract]   [Full Text] [Related]  

  • 7. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H; Auw-Hädrich C
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antioxidative therapy in ceroid lipofuscinosis].
    Rotteveel JJ; Mullaart RA
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):181-6. PubMed ID: 2815055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ocular surface inflammation in Sjögren syndrome.
    Hyon JY; Lee YJ; Yun PY
    Cornea; 2007 Oct; 26(9 Suppl 1):S13-5. PubMed ID: 17881909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
    Jagell S; Lidén S
    Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant treatment in Spielmeyer-Sjögren's disease.
    Santavuori P; Westermarck T; Rapola J; Pohja P; Moren R; Lappi M; Vuonnala U
    Acta Neurol Scand; 1985 Feb; 71(2):136-45. PubMed ID: 3984680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myelopathy - Sjogren's syndrome association: analysis of clinical and radiological findings and clinical course].
    de Seze J; Stojkovic T; Hachulla E; Breteau G; Michon-Pasturel U; Mounier-Vehier F; Hatron PY; Vermersch P
    Rev Neurol (Paris); 2001 Jul; 157(6-7):669-78. PubMed ID: 11458186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prolonged bromhexine therapy on Sjögren's syndrome.
    Nahir AM; Scharf Y; Ben-Aryeh H; Szargel R; Gutman D; Zonis S; Scharf J
    Isr J Med Sci; 1981 Jun; 17(6):403-6. PubMed ID: 6167531
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients.
    Aragona P; Bucolo C; Spinella R; Giuffrida S; Ferreri G
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4474-9. PubMed ID: 16303936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral sequential optic neuropathy as the initial manifestation of Sjögren syndrome.
    Pournaras JA; Vaudaux JD; Borruat FX
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):337-9. PubMed ID: 17458808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe pulmonary hypertension in pediatric primary Sjögren syndrome: a case report.
    Zhang X; Zeng X
    J Clin Rheumatol; 2007 Oct; 13(5):276-7. PubMed ID: 17921797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sociomedical aspects of primary Sjögren's syndrome].
    Bjerrum K; Prause JU
    Ugeskr Laeger; 1990 Jul; 152(29):2113-6. PubMed ID: 2399579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndrome.
    Price EJ; Rigby SP; Clancy U; Venables PJ
    J Rheumatol; 1998 May; 25(5):896-9. PubMed ID: 9598887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of the treatment of Sjögren's syndrome with anti-rheumatic preparations].
    Vasil'ev VI; Simonova MV; Safonova TN; Mach ES
    Ter Arkh; 1988; 60(4):67-72. PubMed ID: 3293255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies.
    Topçu M; Tan H; Yalnizoğlu D; Usubütün A; Saatçi I; Aynaci M; Anlar B; Topaloğlu H; Turanli G; Köse G; Aysun S
    Turk J Pediatr; 2004; 46(1):1-10. PubMed ID: 15074367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.